4.6 Review

Dementia

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 131, Issue 10, Pages 1161-1169

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2018.01.022

Keywords

Clinical care; Cognitive impairment; Dementia; Major neurocognitive disorder; Neurodegenerative disease

Funding

  1. Alzheimer's Innovation Fund of the Alzheimer Center, Brigham and Women's Hospital, Boston, Mass

Ask authors/readers for more resources

Dementia is any decline in cognition that is significant enough to interfere with independent, daily functioning. Dementia is best characterized as a syndrome rather than as one particular disease. The causes of dementia are myriad and include primary neurologic, neuropsychiatric, and medical conditions. It is common for multiple diseases to contribute to any one patient's dementia syndrome. Neurodegenerative demential, like Alzheimer disease and dementia with Lewy bodies, are most common in the elderly, while traumatic brain injury and brain tumors are common causes in younger adults. While the recent decade has seen significant advancements in molecular neuroimaging, in understanding clinico-pathologic correlation, and in the development of novel biomarkers, clinicians still await disease-modifying therapies for neurodegenerative dementias. Until then, clinicians from varied disciplines and medical specialties are well poised to alleviate suffering, aggressively treat contributing conditions, employ medications to improve cognitive, neuropsychiatric, and motor symptoms, promote evidence-based brain-healthy behaviors, and improve overall quality of life for patients and families. (C) 2018 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available